NX Development: Medexus completes agreement with NX Development Corporation to return US commercialization rights for Gleolan
Medexus Pharmaceuticals, a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions, recently completed an
Read full article »
NX Development is a Kentucky-based pharmaceutical company that develops technologies that allow surgeons to visualize brain tumors during surgery.
Read more